Clover Health is positioned for a major turnaround, with operations and profitability metrics improving sharply. See why CLOV stock is a Buy.

Clover Health, an insurtech startup targeting the Medicare Advantage market, will close a new round of funding within the next couple of weeks led by Greenoaks Capital, Clover CEO Vivek Garipalli ...

Clover Health Investments (NASDAQ:CLOV) executives outlined what they described as a repeatable, technology-driven Medicare Advantage model at the Leerink Global Healthcare Conference, emphasizing ...

Nashville, Tenn.-based insurance startup Clover Health is partnering with Nashville, Tenn.-based Thyme Care to collaborate on cancer care for underserved seniors. Announced Sept. 1, the partnership ...

It has been about a month since the last earnings report for Clover Health Investments, Corp. (CLOV). Shares have lost about 11.6% in that time frame, underperforming the S&P 500. Will the recent ...

Clover Health Investments CLOV is well poised for growth in the coming quarters, courtesy of its broad product spectrum. This ...

Federal regulators have fined Clover Health $106,095 for misleading consumers about their out-of-network benefits. Founded in 2012, Clover Health sells Medicare Advantage products in New Jersey. The ...